Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_assertion type Assertion NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_head.
- NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_assertion description "[In a multiple linear-regression analysis, the same variant in the CDC123/CAMKID revealed a marked decrease in fasting insulin levels among 'G' (risk) allele carriers independently in NG controls (P=0.030) and in T2D cases (P=0.009), as well as in the combined sample (P=0.003) after adjusting for covariates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_provenance.
- NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_assertion evidence source_evidence_literature NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_provenance.
- NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_assertion SIO_000772 19247373 NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_provenance.
- NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_assertion wasDerivedFrom befree-2016 NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_provenance.
- NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_assertion wasGeneratedBy ECO_0000203 NP722923.RAR5Efqq5yr6OPokjfj48mNz8MoEwtEGIjU1oL--ulFnA130_provenance.